Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Molecular Weight Heparin for the Treatment of Early Fetal Growth Restriction

NCT04762992 is registered in ClinicalTrials.gov with Centro Hospitalar de Lisboa Central as lead sponsor.

NCT NCT04762992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04762992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Molecular Weight Heparin for the Treatment of Early Fetal Growth Restriction
Lead sponsor
Centro Hospitalar de Lisboa Central
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
July 18, 2022
Completion date
December 30, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth retardation, pre-eclampsia, prematurity